Contact Us


 


Mechanism of Action Video

Occasional slight erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after 1 year of treatment with collagenase and cortisone.

See complete prescribing information for more details.

Use of Collagenase SANTYL® Ointment should be terminated when debridement is complete and granulation tissue is well established.

Intended for US Healthcare Professionals Only.

Collagenase SANTYL® Ointment is indicated for debriding chronic dermal ulcers and severely burned areas. Occasional slight transient erythema has been noted in surrounding tissue when applied outside the wound. One case of systemic hypersensitivity has been reported after 1 year of treatment with collagenase and cortisone.
Use of Collagenase SANTYL® Ointment should be terminated when debridement is complete and granulation tissue is well established.
See complete prescribing information for more details.

Healthpoint and SANTYL are registered trademarks of Healthpoint, Ltd.
© 2011 Healthpoint Biotherapeutics. All rights reserved.
The information on this site is intended for customers, patients, and healthcare professionals in the United States only. All information, including the Prescribing Information for Collagenase SANTYL® Ointment, abides by the laws, regulatory requirements, and medical practices for the United States only and may not be appropriate for use outside of the United States.